After controlling for pathologic features and cancer treatments, positive ER status was the strongest predictor of mortality in this cohort of women with BRCA2-associated breast cancer (HR = 2.08; 95% CI 0.99–4.36, p = 0.05). The gene discussed is BRCA2; the disease is breast carcinoma.